SII’s Cervavac- India’s approved indigenous HPV vaccine to cost Rs 200-400

SII’s Cervavac- India’s approved indigenous HPV vaccine to cost Rs 200-400 The scientific completion of the qHPV vaccine is a moment of pride for us, and India, at large. The indigenously developed vaccine will make our country self-sufficient in curbing female mortality caused by cervical cancer. We would like to thank DBT and BIRAC for supporting us in achieving this significant milestone: Adar Poonawalla https://ift.tt/Lqovpgw